awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50648690-0AADF1B0-2A1A-44B1-A8D3-9CCBFD040B81
Q50648690-0AADF1B0-2A1A-44B1-A8D3-9CCBFD040B81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50648690-0AADF1B0-2A1A-44B1-A8D3-9CCBFD040B81
Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations.
P2860
Q50648690-0AADF1B0-2A1A-44B1-A8D3-9CCBFD040B81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50648690-0AADF1B0-2A1A-44B1-A8D3-9CCBFD040B81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
160532bd0b4a7b8e3563f821b355c2f0b0c81621
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.